Current Fellowships:
Barnes-Jewish Hospital
Carolinas Medical Center
Cleveland Clinic
Duke HPB Oncology Fellowship
Indiana University
Mayo Clinic-Rochester
MD Anderson
McGill University
Medical College Wisconsin
Methodist Dallas
Penn State
Providence Medical Center
Stanford University
University of Michigan
University of Toronto
Virginia Mason Med Center
CETAT CommitteeClick here to access the CETAT Committee area (must be logged in and a member of this committee).
CETAT Committee ChairDavid A. Iannitti, MD, FACSThe Committee on Emerging Technologies and Therapeutic's (CETAT) task is to identify promising emerging technologies and therapeutics applicable to the treatment of pancreatic, liver, and biliary disease that are in the design or development stage. The committee will develop strategies to engage inventors and/or company representatives and serve as a liaison between them and other key members and committees of the AHPBA such as the research, program and development committees. The objective of the committee will be to provide an avenue through the AHPBA sponsored meetings, symposia and research opportunities that can help companies accelerate the introduction of new technology and therapeutics into the clinical arena. David Iannitti, MD, FACS - Chair Arthur James Moser, MD - Vice/Co-Chair Anton J. Bilchik, MD, PhD, FACS Kevin Charpentier, MD Steven A. Curley, MD Jeffrey A. Drebin, MD Yuman Fong, MD Arthur A. Fusco, MD Christos A. Galanopoulos, MD, FACS Mariano Eduardo Gimenez, MD Niraj Gusani, MD William G. Hawkins, MD Michael L. Kendrick, MD Elizabeth A. Pomfret, MD, PhD Ponnandai S. Somasundar, MD Steven M. Strasberg, MD Kenneth K. Tanabe, MD Selwyn M. Vickers, MD, FACS Charles Edouard Zurstrassen, MD William C. Chapman, MD Ex Officio Kim O'Dell Ex-Officio
|